| 782 |
increased |
increased vascular permeability
(MP:0003070)
|
|
1867: Bradykinin system, hyperactivated
|
| 783 |
increased |
vasodilation
(GO:0042311)
|
|
1867: Bradykinin system, hyperactivated
|
| 784 |
increased |
vascular inflammation
(MP:0001863)
|
|
1867: Bradykinin system, hyperactivated
|
| 785 |
morphological change |
retina layer formation
(GO:0010842)
|
retina
(UBERON:0000966)
|
1877: Altered, retinal layer structure
|
| 791 |
decreased |
chloride channel activity
(GO:0005254)
|
|
1906: Cystic Fibrosis Transmembrane Regulator Function, Decreased
|
| 794 |
decreased |
mucociliary clearance trait
(VT:0001947)
|
|
1909: Mucociliary Clearance, Decreased
|
| 797 |
increased |
oxidative phosphorylation uncoupler activity
(GO:0017077)
|
mitochondrion
(GO:0005739)
|
1446: Decrease, Coupling of oxidative phosphorylation
|
| 798 |
decreased |
regulation of mitochondrial membrane potential
(GO:0051881)
|
mitochondrion
(GO:0005739)
|
1446: Decrease, Coupling of oxidative phosphorylation
|
| 799 |
increased |
proton binding
(GO:1901691)
|
mitochondrion
(GO:0005739)
|
1446: Decrease, Coupling of oxidative phosphorylation
|
| 800 |
decreased |
|
epithelial lining fluid
(UBERON:0035963)
|
1907: Airway Surface Liquid Height, Decreased
|
| 802 |
occurrence |
Abnormal ciliary motility
(HP:0012262)
|
motile cilium
(GO:0031514)
|
1908: Cilia Beat Frequency, Decreased
|
| 804 |
increased |
translation
(GO:0006412)
|
mucin-5AC
(PR:000031343)
|
962: Increase, Mucin production
|
| 805 |
increased |
mucus secretion
(GO:0070254)
|
lung goblet cell
(CL:1000143)
|
1251: Chronic, Mucus hypersecretion
|
| 806 |
increased |
NLRP3 inflammasome complex assembly
(GO:0044546)
|
NLRP3 inflammasome complex
(GO:0072559)
|
1895: NLRP3 inflammasome activity, increased
|
| 807 |
decreased |
|
motile cilium
(GO:0031514)
|
1912: Motile Cilia Number/Length, Decreased
|
| 808 |
decreased |
|
forkhead box protein J1
(PR:000007628)
|
1911: FOXJ1 Protein, Decreased
|
| 810 |
functional change |
vision trait
(VT:0002090)
|
eye
(UBERON:0000970)
|
1643: Altered, Visual function
|
| 811 |
increased |
glycosylation
(GO:0070085)
|
mucin-5AC
(PR:000031343)
|
1910: Mucus Viscosity, Increased
|
| 815 |
increased |
mRNA transcription
(GO:0009299)
|
angiotensin-converting enzyme 2
(PR:000003622)
|
1854: Dysregulation, ACE2 expression and activity
|
| 816 |
increased |
carboxypeptidase activity
(GO:0004180)
|
angiotensin-converting enzyme 2
(PR:000003622)
|
1854: Dysregulation, ACE2 expression and activity
|
| 817 |
decreased |
protein localization to cell surface
(GO:0034394)
|
angiotensin-converting enzyme 2
(PR:000003622)
|
1854: Dysregulation, ACE2 expression and activity
|
| 818 |
increased |
|
angiotensin-converting enzyme 2
(PR:000003622)
|
1854: Dysregulation, ACE2 expression and activity
|
| 819 |
increased |
phosphorylation
(GO:0016310)
|
epidermal growth factor receptor
(PR:000006933)
|
941: Activation, EGFR
|
| 820 |
decreased |
apoptotic process
(GO:0006915)
|
ciliated epithelial cell
(CL:0000067)
|
914: Decrease, Apoptosis of ciliated epithelial cells
|
| 823 |
increased |
synaptic transmission, glutamatergic
(GO:0035249)
|
L-glutamate(1-)
(CHEBI:29985)
|
1350: Increased, glutamate
|